Salt, Na+,K+-ATPase and hypertension
Ariel Jaitovich1, Alejandro M Bertorello
1Membrane Signaling Networks, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Solna, 171 76 Stockholm, Sweden. ajaitovich@ccbhs.org
Life Sciences
|November 14, 2009
Summary
High sodium diets can lead to hypertension by affecting kidney function and vascular tone. Understanding these molecular mechanisms, including hormonal mediators and endogenous compounds, is key to developing new hypertension treatments.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Endocrinology
Background:
- Chronic hypertension involves persistent increases in vascular tone.
- Sodium-rich diets are linked to hypertension, but molecular mechanisms remain unclear.
- Hormonal mediators like dopamine and angiotensin II influence renal sodium transport.
Purpose of the Study:
- To elucidate the molecular mechanisms linking dietary sodium to hypertension.
- To explore the role of renal Na(+),K(+)-ATPase activity and endogenous ouabain-like compounds (OLC).
- To identify new therapeutic targets for salt-induced hypertension.
Main Methods:
- Investigated the modulation of renal tubule Na(+),K(+)-ATPase by dietary sodium.
- Examined the effect of OLC on Na(+),K(+)-ATPase activity and vascular smooth muscle cell function.
- Analyzed the impact of altered sodium transport on blood pressure regulation.
Main Results:
- Dietary sodium variations modulate renal Na(+),K,-ATPase activity via hormonal mediators.
- Inhibition of Na(+),K(+)-ATPase increases intracellular Na(+) and Ca(2+) in vascular smooth muscle cells, raising blood pressure.
- High sodium diets stimulate OLC release, contributing to hypertension.
Conclusions:
- Dietary sodium intake significantly impacts vascular tone and blood pressure through complex molecular pathways.
- Understanding these mechanisms offers potential for novel therapeutic strategies for hypertension.
- Further research into salt-induced hypertension pathophysiology is warranted.
More Related Videos
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:14Active Transport
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...